Federal Stimulus Grant to Study Anti-Nicotine Vaccine
An American Recovery and Reinvestment Act grant of 10-million dollars funded by the National Institute on Drug Abuse was awarded to Nabi Biopharmaceuticals for the first pivotal phase II trial of NicVAX, a vaccine that may help people quit smoking and prevent relapse. NicVAX was given fast-track designation by the United States Food and Drug …
Federal Stimulus Grant to Study Anti-Nicotine Vaccine Read More »